http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14139404

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural
endingPage 1019
issn 1387-2877
1875-8908
issueIdentifier 4
pageRange 1009-1019
publicationName Journal of Alzheimer's disease : JAD
startingPage 1009
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_98a810dfee485bc54a2053e6b648393a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1a1d6eb6b2fc297daaf9883eb6dc1ffd
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be5865135fa336fe1d432e40b2df80e7
bibliographicCitation Gleason CE, Fischer BL, Dowling NM, Setchell KD, Atwood CS, Carlsson CM, Asthana S. Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease. J Alzheimers Dis. 2015;47(4):1009–19. PMID: 26401779; PMCID: PMC4657545.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8642-7299
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_836178ff58f75da1125e42af14663f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8258fceca137c2f5ab0813e08b53e419
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ee839ec3d895f26e52c9b83062b52cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e04e6c3663081410ba1af2b04560e778
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2c1cbc03e8646ed129a7c30a6273309
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13216587c89a7926fc8300aa222481cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef797e1970f7d068471205d7191566ff
date 2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/26401779
https://doi.org/10.3233/jad-142958
https://pubmed.ncbi.nlm.nih.gov/PMC4657545
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Cognitive Effects of Soy Isoflavones in Patients with Alzheimer’s Disease
discusses http://id.nlm.nih.gov/mesh/M0011762
http://id.nlm.nih.gov/mesh/M0028009
http://id.nlm.nih.gov/mesh/M0386765
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D007529Q000627
http://id.nlm.nih.gov/mesh/D018697Q000627
http://id.nlm.nih.gov/mesh/D000544Q000178
http://id.nlm.nih.gov/mesh/D019587
http://id.nlm.nih.gov/mesh/D030262Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D018697Q000009
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D007529Q000097
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D007529Q000009
http://id.nlm.nih.gov/mesh/D003071
http://id.nlm.nih.gov/mesh/D012737
http://id.nlm.nih.gov/mesh/D018697Q000097
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D010349
http://id.nlm.nih.gov/mesh/D030262Q000097
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000339
http://id.nlm.nih.gov/mesh/D009048
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D000544Q000523
http://id.nlm.nih.gov/mesh/D000544Q000097
http://id.nlm.nih.gov/mesh/D030262Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91469
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d22ef8d03375d89409872210d728cfc0
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID382975
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Total number of triples: 64.